CompletedPhase 1NCT04603131

Clinical Trial to Evaluate the Immunogenicity of Chikungunya Vaccine

Studying Chikungunya

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Bharat Biotech International Limited
Principal Investigator
Krishna Mohan, PHD
Bharat Biotech International Limited
Intervention
Inactivated Chikungunya virus vaccine 20 mcg(biological)
Enrollment
60 enrolled
Eligibility
18-50 years · All sexes
Timeline
2017 – 2018

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04603131 on ClinicalTrials.gov

Other trials for Chikungunya

Additional recruiting or active studies for the same condition.

See all trials for Chikungunya →

← Back to all trials